XOM
64
8
SE
47
-5
EOG
45
3
T
35
-3
IVZ
55
-8
ETN
63
3
THC
60
-4
FSLR
57
-6
FAST
46
4
PSA
56
5
CRM
52
2
HBAN
79
5
PH
78
3
KR
49
-3
APD
55
3
UNH
37
4
MMC
60
2
F
59
3
STI
13
-2
HOG
45
3
XOM
64
8
SE
47
-5
EOG
45
3
T
35
-3
IVZ
55
-8
ETN
63
3
THC
60
-4
FSLR
57
-6
FAST
46
4
PSA
56
5
CRM
52
2
HBAN
79
5
PH
78
3
KR
49
-3
APD
55
3
UNH
37
4
MMC
60
2
F
59
3
STI
13
-2
HOG
45
3
Financhill
Back

Arvinas, Inc. 10K Form

Buy
55

ARVN
Arvinas, Inc.

Last Price:
$12.55
Seasonality Move:
38.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-04 10Q ARVN/Arvinas, Inc. Quarterly
2020-04-28 10Q ARVN/Arvinas, Inc. Quarterly
2020-03-16 10K ARVN/Arvinas, Inc. Annual
2019-11-04 10Q ARVN/Arvinas, Inc. Quarterly
2019-08-05 10Q ARVN/Arvinas, Inc. Quarterly
2019-05-09 10Q ARVN/Arvinas, Inc. Quarterly

Receive ARVN News And Ratings

See the #1 stock for the next 7 days that we like better than ARVN

ARVN Financial Statistics

Sales & Book Value

Annual Sales: $263.4M
Cash Flow: $-59.2M
Price / Cash Flow: 0
Annual Sales: $7.97
Price / Book: 1.43

Profitability

EPS (TTM): -0.80310
Net Income (TTM): $-58.5M
Gross Margin: $256.8M
Return on Equity: -9.81%
Return on Assets: -5.84%

Arvinas, Inc. Earnings Forecast

Key Arvinas, Inc. Financial Ratios

  • The Gross Profit Margin over the past 9 years for ARVN is 97.49%.
  • The Selling, General & Administrative Expenses for ARVN have been equal to 62.79% of Gross Profit Margin.
  • The Research & Development expenses have been 132.19% of Revenue.
  • The Net Earning history of ARVN is -75.51% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 2 years.

Arvinas, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ARVN
CUSIP: 04335A
Website: arvinas.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 5.7
Quick Ratio: 5.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARVN Technical Analysis vs Fundamental Analysis

Buy
55
Arvinas, Inc. (ARVN) is a Buy

Is Arvinas, Inc. a Buy or a Sell?

  • Arvinas, Inc. stock is rated a Buy
    The current Arvinas, Inc. [ARVN] share price is $12.55. The Score for ARVN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.